Nephrocare Health Services Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 5,769 shares,. Its Average Traded Price (ATP) is ₹623.76, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹624.30.
Nephrocare Health Services has an upper circuit limit of ₹747.15 and a lower circuit limit of ₹498.15. The total value traded stands at ₹35.98 L, and the delivery percentage for the day is 53.9%.
The stock is currently traded with a market lot size of 1. Nephrocare Health Services also offers a dividend yield of 0%.
Nephrocare Health Services Share Price Chart
Nephrocare Health Services Share Key Metrics
Volume
5769.00
Market Cap
6261.31 CR
LTQ@LTP
1@624.30
ATP
623.76
Var Margin
16.16 %
Circuit Range
498.15-747.15
Delivery %
53.9 %
Value
35.98 L
ASM/GSM
No
Market Lot
1
Nephrocare Health Services Resistance and Support
Pivot 627.4
Resistance
First Resistance
634.25
Second Resistance
645.85
Third Resistance
652.7
Support
First Support
615.8
Second Support
608.95
Third Support
597.35
Nephrocare Health Services Shareholding Pattern
View More- 2025-26
- 2026-27
Total Promoters
Nephrocare Health Services Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-10 | Quarterly Results |
Nephrocare Health Services News
Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nephrocare Health Services reported Q2 FY27 revenue of Rs.303.4 crores, up 23.5% YoY, and adjusted PAT of Rs.39.3 crores, up 28.7% YoY. The company expanded its network to 570 clinics across 6 countries, including a new entry into Kazakhstan.
Nov 03 2026 18:18:18
Nephrocare Health Services Ltd - 544647 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 3, 2026.
Nephrocare Health Services reported Q2 FY27 cons. revenue of ₹303.40 crores, up 23.5% YoY, and a net profit of ₹33.53 crores, recovering from a YoY net loss. The company also announced strategic asset acquisitions in the Philippines and Kazakhstan totaling over ₹103 crores.
Nov 03 2026 18:12:15
Nephrocare Health Services Ltd - 544647 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Nephrocare Health Services' wholly-owned subsidiary in the Philippines has entered into an Asset Transfer Agreement with JCM Summit Health Inc. The agreement is for the acquisition of assets relating to a dialysis center in Quezon City.
Oct 27 2026 19:42:25
Nephrocare Health Services Management
| Name | Position |
|---|---|
| Vikram Vuppala | Chairman & Managing Director |
| Vishal Vijay Gupta | Nominee Director of BVP Trust |
Nephrocare Health Services Similar Stocks
Thyrocare Technologies Ltd.
492.05
4.05 (0.83%)
Sanofi India Ltd.
3316.80
35.90 (1.09%)
Bliss GVS Pharma Ltd.
654.00
12.45 (1.94%)
Kovai Medical Center & Hospital Ltd.
6584.50
55.00 (0.84%)
FDC Ltd.
375.95
-14.45 (3.70%)
Innova Captab Ltd.
1146.50
-16.30 (1.40%)
IOL Chemicals And Pharmaceuticals Ltd.
206.10
1.02 (0.50%)
Senores Pharmaceuticals Ltd.
1210.90
-6.10 (0.50%)
Morepen Laboratories Ltd.
98.00
3.10 (3.27%)
Orchid Pharma Ltd.
891.25
33.45 (3.90%)
Nephrocare Health Services FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in NEPHROPLUS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in NEPHROPLUS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade